(MENAFN- Caribbean News World)
NEW YORK–(Organization WIRE)–On Thursday, June 16, 2022, much more than 900 men and women from above 100 companies from the leveraged finance and personal equity communities arrived jointly for the Leveraged Finance Fights Melanoma (LFFM) gain and cocktail celebration. Hosted at the Museum of Fashionable Art, the celebration raised a report breaking $3 million for the Melanoma Investigation Alliance’s (MRA) mission to advance the world’s most ground breaking and promising melanoma study.
“Each year, I carry on to be impressed by the community’s response to this function and the mission it supports,” suggests LFFM co-founder and MRA board member Jeff Rowbottom.“LFFM has turn into a signature occasion for the finance field, and it performs a significant function in advancing most cancers analysis that is literally conserving life, such as mine.”
LFFM funding supports reducing-edge melanoma exploration that has assisted individuals with all forms of most cancers stay extended, fuller life. Remedies initially pioneered in melanoma are now remaining utilized to address people with above 30 other cancer varieties.
LFFM was established in 2011 by Jeff Rowbottom (Iron Park Cash) and Brendan Dillon (Veritas Cash) – the two melanoma survivors. Given that its founding, LFFM has elevated additional than $19 million for MRA, the greatest nonprofit funder of melanoma research. Given that its founding in 2007, MRA-funded investigators have been deeply associated in every single breakthrough in melanoma study, together with the acceptance of 15 new therapies.
The function was co-chaired by Clare Bailhé (MidCap Money), Brendan Dillon (Veritas Funds), Kerry Dolan (Brinley Companions), Lee Grinberg (Elliott Administration), Matt Manin (Apollo), George Mueller (KKR), Geoff Oltmans (Silver Lake), Kevin Pluff , Jeff Rowbottom (Iron Park Cash), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman), and Eric Wedel (Kirkland & Ellis).
Presenting sponsors of the party provided Latham & Watkins, Kirkland & Ellis, Simpson Thacher & Bartlett, Fitch Ratings, Michael Milken, HPS Expense Associates, Apollo|Midcap, Iron Park Cash Management, Veritas Money Management and White & Scenario. A comprehensive listing of LFFM sponsors is involved below.
“The leveraged finance and private equity communities are some of the greatest advocates for MRA and our mission to remedy melanoma,” says MRA CEO Marc Hurlbert, PhD.“The resources lifted from this occasion will more speed up the MRA study agenda and the continuation of speedier cures, new therapies and lifesaving breakthroughs.
LFFM 2022 Sponsors
PRESENTING
Kirkland & Ellis
Latham & Watkins
Simpson Thacher & Bartlett LLP
Michael Milken
Apollo|Midcap
Fitch Scores
HPS Financial investment Partners, LLC
Iron Park Funds
Veritas Capital Management LLC
White & Scenario LLP
PLATINUM
Allen & Overy
BMO Funds Markets
Davis Polk & Wardwell
Joyce and Barry Cohen
Shearman & Sterling LLP
Sidley Austin LLP
UBS Monetary
GOLD
Financial institution of America Merrill Lynch
Barclays Funds
Bloomberg L.P.
Brinley Partners
Citi
Typical Atlantic Philanthropic Foundation
Golub Funds
Hellman & Friedman
Intesa Sanpaolo
King & Spalding LLP
KKR
Leonard Eco-friendly & Associates
Howard and Nancy Marks
Milbank LLP
MJR Foundation
Morgan Stanley
New Mountain Finance Corporation
Proskauer Rose
Ropes & Gray LLP
Silver Lake
Sixth Street Partners
Skadden, Arps, Slate, Meagher & Flom LLP
T. Rowe Cost
TD Securities
The Carlyle Group
Thoma Bravo
Vista Fairness Partners
Weil, Gotshal & Manges LLP
Wells Fargo Lender
Most popular
Jefferies LLC
Credit Suisse
GTCR
Royal Lender of Canada/RBC Money Marketplaces
American Industrial Associates
Ares Management LLC
BC Partners
Blackstone Credit rating
Blue Owl Funds
BNP Paribas
Centerbridge Associates
Clayton, Dubilier & Rice LLC
Cleary Gottlieb Steen & Hamilton
Cravath, Swaine & Moore LLP
Debevoise & Plimpton
Deutsche Bank
Fried, Frank, Harris, Shriver & Jacobson LLP
HIG Funds
HSBC Bank
Macquarie Team
Madison Dearborn Associates
Matt Nord and Erika Weinberg
Mizuho Securities United states of america, Inc.
MJX Asset Administration LLC
MUFG
Oak Hill Advisors, LP
Oak Hill Cash Administration
Silver Rock Monetary
Stone Canyon Industries
Stone Level Money
Sullivan & Cromwell LLP
Wachtell, Lipton, Rosen & Katz
Winston & Strawn
ADVOCATE
Fortinbras
Tiger World
Advent Intercontinental Company
Angelo Gordon & Co.
BlackRock
Brookfield Asset Management
Money A person Lender
Clarion Capital Associates, LLC
GoldenTree Asset Management, LP
Lauren Hanrahan
Houlihan Lokey
LSTA
Natixis
Orchard To start with Supply Asset Management
Paul Hastings LLP
PNC Lender
Riverstone
Rothschild & Co.
Seix Expense Advisors
Shenkman Money Management Inc.
Siris Money Group
Stonepeak Partners
Sumitomo Mitsui Banking Corporation (SMBC)
Stephanie Teicher
Warburg Pincus LLC
Z Money Group
About Melanoma Research Alliance (MRA)
The Melanoma Research Alliance (MRA) stands as the major non-revenue funder of melanoma research. Started in 2007, MRA’s mission is to close struggling and demise thanks to melanoma by advancing the world’s most promising science and research. MRA offers significant funding for melanoma cancer exploration that propels improvements in avoidance, prognosis, remedy, metastasis, and survivorship. MRA-funded researchers have been behind every breakthrough in melanoma study. Given that MRA’s inception, much more than 15 new therapeutic ways for melanoma have gained Food and drug administration acceptance. MRA is identified as one of the most fiscally effective non-gains in the state. Because MRA’s Founders’ generously include 100% of MRA’s administrative and functioning expenditures, just about every dollar donated is invested straight into MRA’s scientific and investigate program. For more details, you should go to: .
LinkedIn: melanoma-exploration-alliance
Twitter: @MelanomaReAlli
Instagram: @melanoma
Fb: MelanomaResearchAlliance
Contacts
Cody R. Barnett, Director of Communications
M: (717) 880-7100
E-mail:
More Media Contacts:
Anreder & Organization
917.923.7011
Steven S. Anreder —
Michael Wichman —
MENAFN17062022000232011072ID1104392577

Authorized Disclaimer: MENAFN offers the information and facts “as is” without guarantee of any kind. We do not acknowledge any responsibility or liability for the precision, material, photographs, movies, licenses, completeness, legality, or trustworthiness of the information contained in this post. If you have any issues or copyright concerns associated to this write-up, kindly contact the supplier above.